VPM1002BC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VPM1002BC, covering 2023-04-13 to 2023-04-13. Get the full timeline:
Most recent: Clinical Trial Update: VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]